Ballicules.com

Trospium and Xanomeline: a Muscarinic acetylcholine receptor interaction

Trospium blocks the muscarinic acetylcholine receptor, so Xanomeline cannot act there — the effect of Xanomeline is reduced or lost.

Xanomeline is an agonist at the muscarinic acetylcholine receptor: it binds and switches the receptor on. Trospium is an antagonist at the same site and switches nothing on. With both present they compete for the same pocket, and whichever is there in greater effective concentration decides what the receptor does.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Xanomeline’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Trospium versus Xanomeline over the Muscarinic acetylcholine receptor
Fight club: Trospium versus Xanomeline — Muscarinic acetylcholine receptor

The two ballicules, with the Muscarinic acetylcholine receptor lit on each

Trospium ballicule, with its Muscarinic acetylcholine receptor peg ringed
Trospium (SANCTURA)
Muscarinic acetylcholine receptor antagonist
Xanomeline ballicule, with its Muscarinic acetylcholine receptor peg ringed
Xanomeline ((in COBENFY))
Muscarinic acetylcholine receptor agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Trospium mascot mnemonic cartoon
Trospium
“Trusty pee-in Sanctuary”
Xanomeline mascot mnemonic cartoon
Xanomeline
“The gnome line”

Open it in the console